Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;237(5):253-7.
doi: 10.1007/BF00450543.

Treatment with an i.v. calcium overload blocker (flunarizine) in acute stroke. A pilot study

P J Hülser  1 , H Bernhart, C Marbach, H H Kornhuber
Affiliations

Treatment with an i.v. calcium overload blocker (flunarizine) in acute stroke. A pilot study

P J Hülser et al. Eur Arch Psychiatry Neurol Sci. 1988.

Abstract

In an open pilot study 55 patients suffering from acute stroke were treated with Flunarizine, a calcium overload blocker, in addition to standard therapy including diet, physiotherapy, adequate management of accompanying disorders, and hemodilution. The initial high-dose i.v. treatment (2 X 25 mg Flunarizine/day) and the subsequent oral regimen were well-tolerated. The main side effect was slight transient weariness. No adverse effects regarding blood pressure, heart rate, enzymes, blood analysis, renal function and, especially, no extrapyramidal motor symptoms or depression were detected. Flunarizine may be regarded as a relatively safe drug in acute stroke. The probable beneficial effect on the patient's recovery will be evaluated in a multicenter double-blind study.

PubMed Disclaimer

References

    1. J Cardiovasc Pharmacol. 1981 Nov-Dec;3(6):1388-412 - PubMed
    1. Dtsch Med Wochenschr. 1987 Jan 23;112(4):157-8 - PubMed
    1. Lancet. 1980 Mar 22;1(8169):613-6 - PubMed
    1. Res Exp Med (Berl). 1985;185(4):325-40 - PubMed
    1. Stroke. 1987 Mar-Apr;18(2):373-9 - PubMed